FI921319A0 - FOERFARANDE FOER FRAMSTAELLNING AV KINOLINDERIVAT. - Google Patents

FOERFARANDE FOER FRAMSTAELLNING AV KINOLINDERIVAT.

Info

Publication number
FI921319A0
FI921319A0 FI921319A FI921319A FI921319A0 FI 921319 A0 FI921319 A0 FI 921319A0 FI 921319 A FI921319 A FI 921319A FI 921319 A FI921319 A FI 921319A FI 921319 A0 FI921319 A0 FI 921319A0
Authority
FI
Finland
Prior art keywords
kinolinderivat
foerfarande foer
foer framstaellning
framstaellning
foerfarande
Prior art date
Application number
FI921319A
Other languages
Finnish (fi)
Other versions
FI921319A (en
Inventor
Arnold Harry Ratcliffe
Emyr Glyn Williams
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of FI921319A0 publication Critical patent/FI921319A0/en
Publication of FI921319A publication Critical patent/FI921319A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI921319A 1990-08-09 1992-03-26 FOERFARANDE FOER FRAMSTAELLNING AV KINOLINDERIVAT. FI921319A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909017479A GB9017479D0 (en) 1990-08-09 1990-08-09 Process
PCT/GB1991/001287 WO1992002508A1 (en) 1990-08-09 1991-07-30 Process for the manufacture of quinoline derivatives

Publications (2)

Publication Number Publication Date
FI921319A0 true FI921319A0 (en) 1992-03-26
FI921319A FI921319A (en) 1992-03-26

Family

ID=10680406

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921319A FI921319A (en) 1990-08-09 1992-03-26 FOERFARANDE FOER FRAMSTAELLNING AV KINOLINDERIVAT.

Country Status (15)

Country Link
EP (1) EP0495948A1 (en)
JP (1) JPH05501728A (en)
KR (1) KR920702357A (en)
CN (1) CN1058965A (en)
AU (1) AU8309091A (en)
CA (1) CA2047249A1 (en)
CS (1) CS88692A3 (en)
FI (1) FI921319A (en)
GB (2) GB9017479D0 (en)
HU (1) HUT60490A (en)
IE (1) IE912406A1 (en)
IL (1) IL98833A0 (en)
PT (1) PT98607A (en)
WO (1) WO1992002508A1 (en)
ZA (1) ZA915567B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
US5484955A (en) * 1992-07-06 1996-01-16 Takeda Chemical Industries, Ltd. Tri-higher alkyl tin azide and its use
US6608048B2 (en) 2000-03-28 2003-08-19 Wyeth Holdings Tricyclic protein kinase inhibitors
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
KR102307175B1 (en) 2013-09-16 2021-10-01 아스트라제네카 아베 Therapeutic polymeric nanoparticles and methods of making and using same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
EP0412848B1 (en) * 1989-08-11 1995-01-18 Zeneca Limited Quinoline derivatives, process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
GB9017479D0 (en) 1990-09-26
EP0495948A1 (en) 1992-07-29
HU9200933D0 (en) 1992-05-28
CN1058965A (en) 1992-02-26
JPH05501728A (en) 1993-04-02
KR920702357A (en) 1992-09-03
CS88692A3 (en) 1992-10-14
FI921319A (en) 1992-03-26
AU8309091A (en) 1992-03-02
PT98607A (en) 1992-06-30
HUT60490A (en) 1992-09-28
WO1992002508A1 (en) 1992-02-20
GB9115250D0 (en) 1991-08-28
CA2047249A1 (en) 1992-02-10
ZA915567B (en) 1992-07-29
IE912406A1 (en) 1992-02-12
IL98833A0 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
FI900779A (en) HYDROMETALLURGISKT FOERFARANDE FOER BEHANDLING AV ZINKSULFIDHALTIGA RAOAEMNEN.
FI901135A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV VAEXTOLJEPRODUKT.
FI900134A (en) FOER IDENTIFIERING AV PLANTOR.
FI900995A (en) TILLSLUTNINGSMEKANISM FOER SUGANORDNINGEN AV EN TANDVAORDSMASKIN.
FI901377A (en) BLAOSANORDNING FOER VINDSPRIDNING AV SPAONOR.
FI900939A0 (en) FOERFARANDE FOER MAERKNING AV TRAESTYCKEN.
FI900107A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV OXALSYRA.
FI910361A (en) FOERFARANDE FOER BEHANDLING AV KOETT.
FI912288A (en) ANVAENDNING AV ENZYMMAERKTA ANTIKROPPFRAGMENT FOER BESTAEMNING AV CHLAMYDIA- ELLER GONOKOCK-ANTIGENER.
FI901059A0 (en) VINKELKONSTRUKTION AV ELDSTAD.
FI900830A0 (en) FOERFARANDE FOER AOTERVINNING AV RETURPRODUKTER.
FI900322A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV GOLVBRAEDE.
FI900448A0 (en) FOERFARANDE FOER OEVERFOERING AV KLUMPPLANTOR.
FI900475A0 (en) FOERFARANDE FOER AOSTADKOMMANDE AV EN LUFTKONDITIONERAD FOERPACKNING.
FI900781A0 (en) AONG- OCH KONDENSATKOPPLING FOER TORKNINGSCYLINDERN AV EN PAPPERMASKIN.
FI900829A (en) DATORBASERAT FOERFARANDE FOER RANGERING AV TAOG.
FI900850A (en) FOERFARANDE FOER SNABB UPPLADDNING AV EN ACKUMULATOR.
FI900386A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV KOMPOSITSKIVPRODUKTER.
FI900977A (en) PULVERKOMPOSITION FOER BILDANDE AV MUNVATTEN.
FI900346A0 (en) ANORDNING FOER UPPSAMLING AV EN KUNDLEVERANSPARTI.
FI901061A (en) ENERGILUCKA FOER UTSIDAN AV FOENSTER.
FI901073A (en) CENTRALVAERMEANORDNING BESTAOENDE AV VAERMESKAOP.
FI900247A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV VAETEGAS.
FI900245A (en) FOERFARANDE FOER BYGGANDE AV TRAEFARTYG.
FI901161A (en) REAKTIONSPRODUKTER AV ALKENYLBAERNSTENSSYRAIMID.

Legal Events

Date Code Title Description
FD Application lapsed